Medline Convenience Kits Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 6,775 units of convenience kits containing recalled lidocaine and bupivacaine injections due to supplier quality issues.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 5, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, devices.
What Happened
Medline Industries, LP initiated a voluntary recall of convenience kits that contain Arrow Kits and Sets including Lidocaine Hydrochloride Injection, USP and Bupivacaine Hydrochloride in Dextrose Injection, USP. The drugs were recalled due to quality issues identified during a recent FDA inspection of the supplier. The recall is classified as Class I and is ongoing.
Which Products Are Affected
The recall covers 22 Medline Convenience Kit models distributed nationwide in the United States, totaling 6,775 units. Affected models include: OPEN HEART CDS (CDS840144Q), OPEN HEART (CDS840150W), OPEN HEART ADULT (CDS840396AA), CABG A CDS (CDS982269N), OPEN HEART ANESTHESIA PACK (CDS983849G), OPEN HEART ACCESSORY CDS (CDS984289L), OPEN HEART A (CDS985105Q), OPEN HEART PART 2 (DYNJ901075R), VPH OPEN HEART (DYNJ902664L), HEART A (DYNJ903465I), HEART (DYNJ903822F), OPEN HEART BASIC B (DYNJ904311F), SM OPEN HEART PACK A&B (DYNJ904749J), OPEN HEART ANESTHESIA ICC-B (DYNJ905567B), SILVER CROSS OPEN HEART (DYNJ906102K), ANESTHESIA OPEN HEART (DYNJ906225I), OPEN HEART COMBO (DYNJ907400F), CARDIAC CABG B (DYNJ908121C), FS OPEN HEART (DYNJ908308A), OPEN HEART SUPPLEMENT (DYNJ909116D), MEM CARDIAC (DYNJ9622573AP), and OPEN HEART A & B PACK (DYNJ9718008AT). Specific lot numbers and UDI-DI codes are listed in FDA recall Z-2453-2026.
What You Should Do
The recall was initiated via letter. Consumers and healthcare facilities should follow instructions provided in the recall notification for affected lots.
Why This Matters
This Class I recall indicates a reasonable probability of serious adverse health consequences or death from the included recalled anesthetic products.
Source
FDA recall number Z-2453-2026, report date 20260701.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,772 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 5, 2026.
Frequently Asked Questions
Common questions about this FDA recall.